NIO-752

N/A

Report date: 2026/05/13 20:02:10
NME

Base Information

Drug NameNIO-752
Drug Alias NameNIO-752
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionMicrotubule-associated protein tau inhibitorsRNA interference
TargetsMicrotubule-associated protein tau
Therapy Area/IndicationsCognitive DysfunctionNeurodegenerative DiseasesAlzheimer Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[12] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesUniversity College LondonNovartis Pharma AgLonza AG +[4] 
Inactive CompaniesN/A
Active IndicationsCognitive DysfunctionNeurodegenerative DiseasesAlzheimer Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A